Atea Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	338	283	254	401	743	3,452
Market Cap Growth	29.05%	11.19%	-36.48%	-46.08%	-78.48%	-
Enterprise Value	12	-198	-338	-261	-96	3,522
Last Close Price	4.46	3.35	3.05	4.81	8.94	41.78
PE Ratio	-	-	-	-	6.13	-
PS Ratio	-	-	-	-	2.11	70.97
PB Ratio	1.10	0.65	0.46	0.63	1.05	6.30
P/TBV Ratio	1.08	0.65	0.46	0.63	1.05	6.30
P/FCF Ratio	-	-	-	-	-	11.63
P/OCF Ratio	-	-	-	-	-	11.63
EV/Sales Ratio	-	-	-	-	-	72.42
EV/FCF Ratio	-	-	-	-	-	11.87
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0	-
Debt / EBITDA Ratio	-	-	-	-	0.00	-
Asset Turnover	-	-	-	-	0.43	0.11
Quick Ratio	16.32	24.44	18.04	35.00	13.44	2.71
Current Ratio	16.66	24.85	18.24	35.77	13.58	2.73
Return on Equity (ROE)	-37.98%	-33.88%	-22.74%	-17.16%	19.27%	-3.86%
Return on Assets (ROA)	-23.86%	-15.60%	-11.94%	-9.65%	10.57%	-1.56%
Return on Capital Employed (ROCE)	-49.30%	-29.60%	-21.40%	-17.10%	19.30%	-2.00%
Earnings Yield	-43.16%	-59.51%	-53.42%	-28.93%	16.31%	-0.32%
FCF Yield	-39.40%	-47.89%	-33.56%	-30.68%	-11.71%	8.60%
Buyback Yield / Dilution	1.10%	-1.05%	-0.17%	5.67%	-308.70%	-113.98%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q